Go to main content
Contact us
20 JUN 2016, 08:00
PRESS RELEASE
REGULATORY

Täby, 20 June, 2016 - Mycronic AB (publ), has received order for an FPS mask writer within the multi-purpose segment from a new customer in Asia. The system is scheduled for delivery during the first half year of 2017.

Mycronic offers mask writers for manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market. The multi-purpose market is a broad segment comprising many different application areas, including touch screen photomasks and electronic packaging.

“We are pleased to welcome a new customer. The customer has chosen the Mycronic FPS system as it provides flexibility and reliability to secure a cost effective photomask manufacturing for a wide variety of application areas”, says Magnus Råberg, Senior VP and General Manager Pattern Generators of Mycronic AB. “The customer also appreciates our broad and reliable service offering, and has now contributed to yet another order in this competitive market.”

The multi-purpose market is a good complement to Mycronic’s mask writers for advanced displays. The price level for an FPS is between USD 1.5–4 million, depending on configuration and customization.

Contacts at Mycronic:
Magnus Råberg
Sr VP & General Manager PG
Tel: +46 8 638 52 00
magnus.raberg@mycronic.com

Per Ekstedt
CFO
Tel: +46 8 638 52 00
per.ekstedt@mycronic.com

 

About Mycronic AB
Mycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, Singapore, South Korea, the Netherlands, United Kingdom and the United States. For more information see our web site at:
www.mycronic.com 

Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.

The information is of the type that Mycronic is required to disclose under the Financial Instruments trading Act and/or the Swedish Securities Markets Act and was submitted for publication at 8 am on 20 June, 2016.